The DOI matches its Crossref record; 230 of the 230 references it cites were found in a registry or an index.
Oral delivery of therapeutic peptides and proteins: Technology landscape of lipid-based nanocarriers
Open accessAbstract
The oral administration of therapeutic peptides and proteins is favoured from a patient and commercial point of view. In order to reach the systemic circulation after oral administration, these drugs have to overcome numerous barriers including the enzymatic, sulfhydryl, mucus and epithelial barrier. The development of oral formulations for therapeutic peptides and proteins is therefore necessary. Among the most promising formulation approaches are lipid-based nanocarriers such as oil-in-water nanoemulsions, self-emulsifying drug delivery systems (SEDDS), solid lipid nanoparticles (SLN), nanostructured lipid carriers (NLC), liposomes and micelles. As the lipophilic character of therapeutic peptides and proteins can be tremendously increased such as by the formation of hydrophobic ion pairs (HIP) with hydrophobic counter ions, they can be incorporated in the lipophilic phase of these carriers. Since gastrointestinal (GI) peptidases as well as sulfhydryl compounds such as glutathione and dietary proteins are too hydrophilic to enter the lipophilic phase of these carriers, the incorporated therapeutic peptide or protein is protected towards enzymatic degradation as well as unintended thiol/disulfide exchange reactions. Stability of lipid-based nanocarriers towards lipases can be provided by the use to excipients that are not or just poorly degraded by these enzymes. Nanocarriers with a size <200 nm and a mucoinert surface such as PEG or zwitterionic surfaces exhibit high mucus permeating properties. Having reached the underlying absorption membrane, lipid-based nanocarriers enable paracellular and lymphatic drug uptake, induce endocytosis and transcytosis or simply fuse with the cell membrane releasing their payload into the systemic circulation. Numerous in vivo studies provide evidence for the potential of these delivery systems. Within this review we provide an overview about the different barriers for oral peptide and protein delivery, highlight the progress made on lipid-based nanocarriers in order to overcome them and discuss strengths and weaknesses of these delivery systems in comparison to other technologies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751
Microemulsion-based media as novel drug delivery systems
Lawrence, M. J., & Rees, G. D. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00103-4 · Cited by 2,040
The Future of Peptide‐based Drugs
Craik, D. J., Fairlie, D. P., Liras, S., & Price, D. (2013) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12055 · Cited by 1,979
McClements, D. J., & Rao, J. (2011) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2011.559558 · Cited by 1,630
Nanoemulsion: Concepts, development and applications in drug delivery
Singh, Y., Meher, J. G., Raval, K., Khan, F. A., Chaurasia, M., Jain, N. K., & Chourasia, M. K. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.03.008 · Cited by 1,358
Solid lipid nanoparticles as a drug delivery system for peptides and proteins☆
ALMEIDA, A., & SOUTO, E. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.04.007 · Cited by 814
Microfold (M) cells: important immunosurveillance posts in the intestinal epithelium
Mabbott, N. A., Donaldson, D. S., Ohno, H., Williams, I. R., & Mahajan, A. (2013) · Mucosal Immunology · doi:10.1038/mi.2013.30 · Cited by 721
Preparation, Characterization and Applications of Liposomes: State of the Art
Laouini, A., Jaafar-Maalej, C., Limayem-Blouza, I., Sfar, S., Charcosset, C., & Fessi, H. (2012) · Journal of Colloid Science and Biotechnology · doi:10.1166/jcsb.2012.1020 · Cited by 692
Non-invasive delivery strategies for biologics
Anselmo, A. C., Gokarn, Y., & Mitragotri, S. (2019) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.183 · Cited by 665
Advances in oral peptide therapeutics
Drucker, D. J. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0053-0 · Cited by 646
Maier, M. A., Jayaraman, M., Matsuda, S., Liu, J., Barros, S., Querbes, W., Tam, Y. K., Ansell, S. M., Kumar, V., Qin, J., et al. (2013) · Molecular Therapy · doi:10.1038/mt.2013.124 · Cited by 625
Xu, Q., Ensign, L. M., Boylan, N. J., Schön, A., Gong, X., Yang, J.-C., Lamb, N. W., Cai, S., Yu, T., Freire, E., et al. (2015) · ACS Nano · doi:10.1021/acsnano.5b03876 · Cited by 568
Transcellular Stomach Absorption of a Derivatized Glucagon-Like Peptide-1 Receptor Agonist
Buckley, S. T., Bækdal, T. A., Vegge, A., Maarbjerg, S. J., Pyke, C., Ahnfelt-Rønne, J., Madsen, K. G., Schéele, S. G., Alanentalo, T., Kirk, R. K., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aar7047 · Cited by 553
Diffusion of Macromolecules and Virus-Like Particles in Human Cervical Mucus
Olmsted, S. S., Padgett, J. L., Yudin, A. I., Whaley, K. J., Moench, T. R., & Cone, R. A. (2001) · Biophysical Journal · doi:10.1016/s0006-3495(01)75844-4 · Cited by 544
Nanoparticles: Emerging carriers for drug delivery
Mudshinge, S. R., Deore, A. B., Patil, S., & Bhalgat, C. M. (2011) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2011.04.001 · Cited by 543
Materials for oral delivery of proteins and peptides
Brown, T. D., Whitehead, K. A., & Mitragotri, S. (2019) · Nature Reviews Materials · doi:10.1038/s41578-019-0156-6 · Cited by 520
Oral lipid-based drug delivery systems – an overview
Kalepu, S., Manthina, M., & Padavala, V. (2013) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2013.10.001 · Cited by 494
Pavoni, L., Perinelli, D. R., Bonacucina, G., Cespi, M., & Palmieri, G. F. (2020) · Nanomaterials · doi:10.3390/nano10010135 · Cited by 469
Nanostructured lipid carriers system: Recent advances in drug delivery
Iqbal, M. A., Md, S., Sahni, J. K., Baboota, S., Dang, S., & Ali, J. (2012) · Journal of Drug Targeting · doi:10.3109/1061186x.2012.716845 · Cited by 436
Ganesan, P., & Narayanasamy, D. (2017) · Sustainable Chemistry and Pharmacy · doi:10.1016/j.scp.2017.07.002 · Cited by 434
Polymeric mixed micelles as nanomedicines: Achievements and perspectives
Cagel, M., Tesan, F. C., Bernabeu, E., Salgueiro, M. J., Zubillaga, M. B., Moretton, M. A., & Chiappetta, D. A. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.12.019 · Cited by 417
Lipid – An emerging platform for oral delivery of drugs with poor bioavailability
Chakraborty, S., Shukla, D., Mishra, B., & Singh, S. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2009.06.001 · Cited by 411
Shan, W., Zhu, X., Liu, M., Li, L., Zhong, J., Sun, W., Zhang, Z., & Huang, Y. (2015) · ACS Nano · doi:10.1021/acsnano.5b00028 · Cited by 395
Microemulsions: A Potential Delivery System for Bioactives in Food
Flanagan, J., & Singh, H. (2006) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408690590956710 · Cited by 394
Wu, J., Lin, W., Wang, Z., Chen, S., & Chang, Y. (2012) · Langmuir · doi:10.1021/la300394c · Cited by 388
Intestinal permeation enhancers for oral peptide delivery
Maher, S., Mrsny, R. J., & Brayden, D. J. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.06.005 · Cited by 381
Ionic liquids for oral insulin delivery
Banerjee, A., Ibsen, K., Brown, T., Chen, R., Agatemor, C., & Mitragotri, S. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1722338115 · Cited by 378
Lipid-based formulations for intestinal lymphatic delivery
O’Driscoll, C. M. (2002) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(02)00051-9 · Cited by 372
Mucus-Penetrating Nanoparticles for Vaginal Drug Delivery Protect Against Herpes Simplex Virus
Ensign, L. M., Tang, B. C., Wang, Y.-Y., Tse, T. A., Hoen, T., Cone, R., & Hanes, J. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003453 · Cited by 368
Oral delivery of proteins and peptides: Challenges, status quo and future perspectives
Zhu, Q., Chen, Z., Paul, P. K., Lu, Y., Wu, W., & Qi, J. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.04.001 · Cited by 353
Oral delivery of macromolecular drugs: Where we are after almost 100 years of attempts
Moroz, E., Matoori, S., & Leroux, J.-C. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.01.010 · Cited by 336
Advanced drug delivery to the lymphatic system: lipid-based nanoformulations
Darwis, Y., Ali Khan, A., Mudassir, J., & Mohtar, N. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s41521 · Cited by 333
Lipid–Drug Conjugate for Enhancing Drug Delivery
Irby, D., Du, C., & Li, F. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b01027 · Cited by 331
Tan, D. K., Maniruzzaman, M., & Nokhodchi, A. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10040203 · Cited by 329
Singh, B., Bandopadhyay, S., Kapil, R., Singh, R., & katare, O. P. (2009) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v26.i5.10 · Cited by 325
Maisel, K., Ensign, L., Reddy, M., Cone, R., & Hanes, J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.10.026 · Cited by 319
Lyophilization/Freeze Drying - An Review
Nireesha, G., Divya, L. S., Sowmya, C., Venkateshan, N., Babu, M. N., & Lavakumar, V. (2013) · International Journal of Novel Trends in Pharmaceutical Sciences · Cited by 313
Bernkop-Schnürch, A. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00204-6 · Cited by 309
Self-citationSelective Filtering of Particles by the Extracellular Matrix: An Electrostatic Bandpass
Lieleg, O., Baumgärtel, R. M., & Bausch, A. R. (2009) · Biophysical Journal · doi:10.1016/j.bpj.2009.07.009 · Cited by 304
Oral bioavailability of cyclosporine: Solid lipid nanoparticles (SLN®) versus drug nanocrystals
Müller, R. H., Runge, S., Ravelli, V., Mehnert, W., Thünemann, A. F., & Souto, E. B. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.02.045 · Cited by 304
Absorption and distribution of dietary fatty acids from different sources
Ramı́rez, M., Amate, L., & Gil, A. (2001) · Early Human Development · doi:10.1016/s0378-3782(01)00211-0 · Cited by 299
Drug Delivery via Cell Membrane Fusion Using Lipopeptide Modified Liposomes
Yang, J., Bahreman, A., Daudey, G., Bussmann, J., Olsthoorn, R. C. L., & Kros, A. (2016) · ACS Central Science · doi:10.1021/acscentsci.6b00172 · Cited by 299
Zwitterionic micelles efficiently deliver oral insulin without opening tight junctions
Han, X., Lu, Y., Xie, J., Zhang, E., Zhu, H., Du, H., Wang, K., Song, B., Yang, C., Shi, Y., et al. (2020) · Nature Nanotechnology · doi:10.1038/s41565-020-0693-6 · Cited by 296
Enzymatic barriers for GI peptide and protein delivery.
Woodley, J. F. (1994) · PubMed · Cited by 291
Liposomes as carriers of enzymes or drugs: a new approach to the treatment of storage diseases
Gregoriadis, G., & Ryman, B. E. (1971) · Biochemical Journal · doi:10.1042/bj1240058p · Cited by 286
Lectin-modified solid lipid nanoparticles as carriers for oral administration of insulin
Zhang, N., Ping, Q., Huang, G., Xu, W., Cheng, Y., & Han, X. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.07.026 · Cited by 286
LIU, J., GONG, T., WANG, C., ZHONG, Z., & ZHANG, Z. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.03.009 · Cited by 282
Solid lipid nanoparticles: an oral bioavailability enhancer vehicle
Harde, H., Das, M., & Jain, S. (2011) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2011.604311 · Cited by 281
The Discovery of Insulin: An Important Milestone in the History of Medicine
Vecchio, I., Tornali, C., Bragazzi, N. L., & Martini, M. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00613 · Cited by 272
Hydrophobic ion pairing: encapsulating small molecules, peptides, and proteins into nanocarriers
Ristroph, K. D., & Prud'homme, R. K. (2019) · Nanoscale Advances · doi:10.1039/c9na00308h · Cited by 262
Ashok, B., Arleth, L., Hjelm, R. P., Rubinstein, I., & Önyüksel, H. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20150 · Cited by 255
Systemic delivery of peptides by the oral route: Formulation and medicinal chemistry approaches
Brayden, D. J., Hill, T. A., Fairlie, D. P., Maher, S., & Mrsny, R. J. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.05.007 · Cited by 253
Niu, M., Lu, Y., Hovgaard, L., Guan, P., Tan, Y., Lian, R., Qi, J., & Wu, W. (2012) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2012.02.009 · Cited by 248
Oral Delivery of Biologics for Precision Medicine
Durán‐Lobato, M., Niu, Z., & Alonso, M. J. (2020) · Advanced Materials · doi:10.1002/adma.201901935 · Cited by 246
Permeation enhancing polymers in oral delivery of hydrophilic macromolecules: thiomer/GSH systems
Bernkop-Schnürch, A. (2003) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.05.001 · Cited by 244
Self-citationYuan, H., Chen, C.-Y., Chai, G.-H., Du, Y.-Z., & Hu, F.-Q. (2013) · Molecular Pharmaceutics · doi:10.1021/mp300649z · Cited by 234
Amino acid-based surfactants – do they deserve more attention?
Bordes, R., & Holmberg, K. (2015) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2014.10.013 · Cited by 229
Safety and efficacy of sodium caprate in promoting oral drug absorption: from in vitro to the clinic
Maher, S., Leonard, T. W., Jacobsen, J., & Brayden, D. J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.09.006 · Cited by 227
Recent Advances in Protein and Peptide Drug Delivery Systems
Kumar Malik, D., Baboota, S., Ahuja, A., Hasan, S., & Ali, J. (2007) · Current Drug Delivery · doi:10.2174/156720107780362339 · Cited by 216
Edible lipid nanoparticles: Digestion, absorption, and potential toxicity
McClements, D. J. (2013) · Progress in Lipid Research · doi:10.1016/j.plipres.2013.04.008 · Cited by 215
Oral insulin delivery: how far are we?
Fonte, P., Araújo, F., Reis, S., & Sarmento, B. (2013) · Journal of Diabetes Science and Technology · doi:10.1177/193229681300700228 · Cited by 211
Beloqui, A., Solins, M. N., Gascn, A. R., del Pozo-Rodrguez, A., des Rieux, A., & Prat, V. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.12.021 · Cited by 208
Engineering nanomaterials to overcome the mucosal barrier by modulating surface properties
Wu, L., Shan, W., Zhang, Z., & Huang, Y. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.10.001 · Cited by 201
MULLER, R. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.07.006 · Cited by 199
Biotinylated liposomes as potential carriers for the oral delivery of insulin
Zhang, X., Qi, J., Lu, Y., He, W., Li, X., & Wu, W. (2014) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2013.07.011 · Cited by 194
Peptide-loaded solid lipid nanoparticles (SLN): Influence of production parameters
Almeida, A. J., Runge, S., & Müller, R. H. (1997) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(97)04885-0 · Cited by 193
Novel Nanomicellar Formulation Approaches for Anterior and Posterior Segment Ocular Drug Delivery
Cholkar, K., Patel, A., Dutt Vadlapudi, A., & K. Mitra, A. (2012) · Recent Patents on Nanomedicinee · doi:10.2174/1877912311202020082 · Cited by 193
Noble, S., & Markham, A. (1995) · Drugs · doi:10.2165/00003495-199550050-00009 · Cited by 191
Nano-carrier systems: Strategies to overcome the mucus gel barrier
Dünnhaupt, S., Kammona, O., Waldner, C., Kiparissides, C., & Bernkop-Schnürch, A. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.01.022 · Cited by 187
Self-citationOral Nanoparticles Exhibit Specific High-Efficiency Intestinal Uptake and Lymphatic Transport
Kim, K. S., Suzuki, K., Cho, H., Youn, Y. S., & Bae, Y. H. (2018) · ACS Nano · doi:10.1021/acsnano.8b04315 · Cited by 187
Enhanced oral absorption of insulin-loaded liposomes containing bile salts: A mechanistic study
Niu, M., Tan, Y., Guan, P., Hovgaard, L., Lu, Y., Qi, J., Lian, R., Li, X., & Wu, W. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.11.028 · Cited by 182
Friedl, H., Dünnhaupt, S., Hintzen, F., Waldner, C., Parikh, S., Pearson, J. P., Wilcox, M. D., & Bernkop-Schnürch, A. (2013) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23757 · Cited by 180
Self-citationShan, W., Zhu, X., Tao, W., Cui, Y., Liu, M., Wu, L., Li, L., Zheng, Y., & Huang, Y. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b08183 · Cited by 180
Donovan, M. D., Flynn, G. L., & Amidon, G. L. (1990) · Pharmaceutical Research · doi:10.1023/a:1015921101465 · Cited by 178
SEDDS: A game changing approach for the oral administration of hydrophilic macromolecular drugs
Mahmood, A., & Bernkop-Schnürch, A. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.07.001 · Cited by 176
Self-citationSelf-nanoemulsifying drug delivery systems (SNEDDS) for oral delivery of protein drugs
Venkata Ramana Rao, S., & Shao, J. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.05.018 · Cited by 172
Preparation and characterization of solid lipid nanoparticles containing peptide
Hu, F. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.12.016 · Cited by 168
Recent Developments in Protein and Peptide Parenteral Delivery Approaches
Patel, A., Cholkar, K., & Mitra, A. K. (2014) · Therapeutic Delivery · doi:10.4155/tde.14.5 · Cited by 166
Martins, S., Costa-Lima, S., Carneiro, T., Cordeiro-da-Silva, A., Souto, E. B., & Ferreira, D. C. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.03.032 · Cited by 165
Wu, W., Niu, M., Lu, Y., & Hovgaard, L. (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s19917 · Cited by 159
Xie, S., Zhu, L., Dong, Z., Wang, X., Wang, Y., Li, X., & Zhou, W. (2010) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2010.12.014 · Cited by 156
Oral Semaglutide: A Review of the First Oral Glucagon-Like Peptide 1 Receptor Agonist
Bucheit, J. D., Pamulapati, L. G., Carter, N., Malloy, K., Dixon, D. L., & Sisson, E. M. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0185 · Cited by 156
Wu, J., Zheng, Y., Liu, M., Shan, W., Zhang, Z., & Huang, Y. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b16524 · Cited by 155
Oral insulin – a review of current status
Iyer, H. V., Khedkar, A., & Verma, M. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01150.x · Cited by 154
Oral Insulin and Buccal Insulin: A Critical Reappraisal
Heinemann, L., & Jacques, Y. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300323 · Cited by 154
A microneedle platform for buccal macromolecule delivery
Caffarel–Salvador, E., Kim, S.-Y., Soares, V. V., Tian, R. Y., Stern, S. R., Minahan, D. J., Yona, R., Lu, X., Zakaria, F. R., Collins, J. E., et al. (2021) · Science Advances · doi:10.1126/sciadv.abe2620 · Cited by 153
Marschütz, M. K., & Bernkop‐Schnürch, A. (2000) · Biomaterials · doi:10.1016/s0142-9612(00)00039-9 · Cited by 151
Self-citationSolid Lipid Nanoparticles in Lymph and Plasma After Duodenal Administration to Rats
Bargoni, A., Cavalli, R., Caputo, O., Fundaro', A., Gasco, M. R., & Zara, G. P. (1998) · Pharmaceutical Research · doi:10.1023/a:1011975120776 · Cited by 148
Maisel, K., Reddy, M., Xu, Q., Chattopadhyay, S., Cone, R., Ensign, L. M., & Hanes, J. (2016) · Nanomedicine · doi:10.2217/nnm-2016-0047 · Cited by 147
Drug Encapsulation Using Supercritical Fluid Extraction of Emulsions
Chattopadhyay, P., Huff, R., & Shekunov, B. Y. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20555 · Cited by 147
The emerging role of P-glycoprotein inhibitors in drug delivery: a patent review
Akhtar, N., Ahad, A., Khar, R. K., Jaggi, M., Aqil, M., Iqbal, Z., Ahmad, F. J., & Talegaonkar, S. (2011) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2011.561784 · Cited by 147
In vivo evaluation of an oral self-microemulsifying drug delivery system (SMEDDS) for leuprorelin
Hintzen, F., Perera, G., Hauptstein, S., Muller, C. R., Laffleur, F., & Bernkop‐Schnürch, A. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.05.047 · Cited by 147
Self-citationNovel Solid Lipid Nanoparticle with Endosomal Escape Function for Oral Delivery of Insulin
Xu, Y., Zheng, Y., Wu, L., Zhu, X., Zhang, Z., & Huang, Y. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b00507 · Cited by 147
Self-emulsifying peptide drug delivery systems: How to make them highly mucus permeating
Griesser, J., Hetényi, G., Kadas, H., Demarne, F., Jannin, V., & Bernkop‐Schnürch, A. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.01.018 · Cited by 145
Self-citationEnhanced intestinal absorption of salmon calcitonin (sCT) from proliposomes containing bile salts
Song, K., Chung, S., & Shim, C. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.05.016 · Cited by 144
Yıldız, H., McKelvey, C. A., Marsac, P. J., & Carrier, R. L. (2015) · Journal of drug targeting · doi:10.3109/1061186x.2015.1086359 · Cited by 143
Liposomes coated with thiolated chitosan enhance oral peptide delivery to rats
Gradauer, K., Barthelmes, J., Vonach, C., Almer, G., Mangge, H., Teubl, B. J., Roblegg, E., Dünnhaupt, S., Fröhlich, E., Bernkop‐Schnürch, A., et al. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.10.011 · Cited by 143
Self-citationOral peptide and protein delivery: intestinal obstacles and commercial prospects
Smart, A. L., Gaisford, S., & Basit, A. W. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.917077 · Cited by 143
Solid self emulsifying drug delivery system: Superior mode for oral delivery of hydrophobic cargos
Maji, I., Mahajan, S., Sriram, A., Medtiya, P., Vasave, R., Khatri, D. K., Kumar, R., Singh, S. B., Madan, J., & Singh, P. K. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.08.013 · Cited by 143
Uchiyama, T., Sugiyama, T., Quan, Y., Kotani, A., Okada, N., Fujita, T., Muranishi, S., & Yamamoto, A. (1999) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357991776976 · Cited by 142
Balata, G. F., Eassa, E., Shamrool, H., Zidan, S., & Abourehab, M. A. S. (2016) · Drug Design Development and Therapy · doi:10.2147/dddt.s95905 · Cited by 141
Recent advances in microneedles-mediated transdermal delivery of protein and peptide drugs
Liu, T., Chen, M., Fu, J., Sun, Y. H., Lu, C. T., Quan, G., Pan, X., & Wu, C. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.03.003 · Cited by 138
Recent approaches of lipid-based delivery system for lymphatic targeting via oral route
Chaudhary, S., Garg, T., Murthy, R. S. R., Rath, G., & Goyal, A. K. (2014) · Journal of drug targeting · doi:10.3109/1061186x.2014.950664 · Cited by 132
In vivo evaluation of an oral self-emulsifying drug delivery system (SEDDS) for exenatide
Menzel, C., Holzeisen, T., Laffleur, F., Zaichik, S., Abdulkarim, M., Gumbleton, M., & Bernkop‐Schnürch, A. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.03.018 · Cited by 132
Self-citationHu, X., Zhang, J., Yu, Z., Xie, Y., He, H., Qi, J., Dong, X., Lü, Y., Zhao, W., & Wu, W. (2015) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2015.06.013 · Cited by 131
Solidification to improve the biopharmaceutical performance of SEDDS: Opportunities and challenges
Joyce, P. M., Dening, T. J., Meola, T. R., Schultz, H. B., Holm, R., Thomas, N., & Prestidge, C. A. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.11.006 · Cited by 131
Effective incorporation of insulin in mucus permeating self-nanoemulsifying drug delivery systems
Karamanidou, T., Karidi, K., Bourganis, V., Kontonikola, K., Kammona, O., & Kiparissides, C. A. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.04.013 · Cited by 127
Kalhapure, R. S., Mocktar, C., Sikwal, D. R., Sonawane, S. J., Kathiravan, M. K., Skelton, A. A., & Govender, T. (2014) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2014.02.045 · Cited by 124
Structure and Dynamics of Highly PEG-ylated Sterically Stabilized Micelles in Aqueous Media
Vuković, L., Khatib, F. A., Drake, S. P., Madriaga, A., Brandenburg, K. S., Král, P., & Önyüksel, H. (2011) · Journal of the American Chemical Society · doi:10.1021/ja204043b · Cited by 123
Thymopentin in solid lipid nanoparticles
Morel, S., Ugazio, E., Cavalli, R., & Gasco, M. R. (1996) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(95)04388-8 · Cited by 123
Self-nanoemulsifying drug delivery system (SNEDDS) for oral delivery of protein drugs
Rao, S. V. R., Yajurvedi, K., & Shao, J. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.05.015 · Cited by 122
Drying technology strategies for colon-targeted oral delivery of biopharmaceuticals
Vass, P., Démuth, B., Hirsch, E., Nagy, B., Andersen, S. K., Vígh, T., Verreck, G., Csontos, I., Nagy, Z. K., & Marosi, G. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.01.023 · Cited by 122
Evidence does not support absorption of intact solid lipid nanoparticles via oral delivery
Hu, X., Fan, W., Yu, Z., Lü, Y., Qi, J., Zhang, J., Dong, X., Zhao, W., & Wu, W. (2015) · Nanoscale · doi:10.1039/c5nr07474f · Cited by 120
Werle, M., & Takeuchi, H. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.11.013 · Cited by 118
Engineered knottin peptides as diagnostics, therapeutics, and drug delivery vehicles
Kintzing, J. R., & Cochran, J. R. (2016) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2016.08.022 · Cited by 118
Stano, P., Bufali, S., Pisano, C., Bucci, F., Barbarino, M., Santaniello, M., Carminati, P., & Luisi, P. L. (2004) · Journal of Liposome Research · doi:10.1081/lpr-120039794 · Cited by 117
Ansari, M. J., Anwer, M. K., Jamil, S., Al-Shdefat, R., Ali, B. E., Ahmad, M. M., & Ansari, M. N. (2015) · Drug Delivery · doi:10.3109/10717544.2015.1039666 · Cited by 115
Solid lipid nanoparticles produced through a coacervation method
Battaglia, L., Gallarate, M., Cavalli, R., & Trotta, M. (2010) · Journal of Microencapsulation · doi:10.3109/02652040903031279 · Cited by 113
PREPARATION AND PROPERTIES OF ETHER‐INJECTION LIPOSOMES *
Deamer, D. W. (1978) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1978.tb22027.x · Cited by 111
Do drug release studies from SEDDS make any sense?
Bernkop‐Schnürch, A., & Jalil, A. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.12.027 · Cited by 111
Self-citationYoo, H. S., & Park, T. G. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10573 · Cited by 110
Overcoming poor permeability: translating permeation enhancers for oral peptide delivery
Maher, S., & Brayden, D. J. (2011) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2011.11.006 · Cited by 107
Li, P., Tan, A., Prestidge, C. A., Nielsen, H. M., & Müllertz, A. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.10.039 · Cited by 105
New perspectives in oral peptide delivery
Zizzari, A. T., Pliatsika, D., Gall, F. M., Fischer, T., & Riedl, R. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.01.020 · Cited by 105
Hydrophobic ion pairing of an insulin-sodium deoxycholate complex for oral delivery of insulin
Cui, F. (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s26450 · Cited by 103
Liposomal Lactoferrin as Potential Preventative and Cure for COVID-19
Serrano, G., Kochergina, I., Albors, A., Diaz, E., Oroval, M., Hueso, G., & Serrano, J. M. (2020) · International Journal of Research in Health Sciences · doi:10.5530/ijrhs.8.1.3 · Cited by 103
Buccal delivery of small molecules and biologics: of mucoadhesive polymers, films, and nanoparticles
Morales, J. O., & Brayden, D. J. (2017) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2017.07.011 · Cited by 102
Antibacterial microemulsion prevents sepsis and triggers healing of wound in wistar rats
Ghosh, V., Saranya, S. R., Mukherjee, A., & Chandrasekaran, N. (2013) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2013.01.009 · Cited by 101
Christiansen, A., Backensfeld, T., & Weitschies, W. (2010) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2010.07.005 · Cited by 98
Brayden, D. J., & Maher, S. (2021) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2021.1942838 · Cited by 98
Aramaki, Y., Tomizawa, H., Hara, T., Yachi, K., Kikuchi, H., & TSUCHIYA, S. (1993) · Pharmaceutical Research · doi:10.1023/a:1018936806278 · Cited by 97
Biological fate of ingested lipid-based nanoparticles: current understanding and future directions
Wang, T., & Luo, Y. (2019) · Nanoscale · doi:10.1039/c9nr03025e · Cited by 96
Tankó, L. B., Bagger, Y. Z., Alexandersen, P., Devogelaer, J.-P., Reginster, J., Chick, R., Olson, M. S., Benmammar, H., Mindeholm, L., Azria, M., et al. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040715 · Cited by 94
Feeney, O. M., Williams, H. D., Pouton, C. W., & Porter, C. J. H. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.07.037 · Cited by 93
Cyclosporine A: A Review of Current Oral and Intravenous Delivery Systems
Beauchesne, P. R., Chung, N., & Wasan, K. M. (2007) · Drug Development and Industrial Pharmacy · doi:10.1080/03639040601155665 · Cited by 92
Hetényi, G., Griesser, J., Moser, M., Demarne, F., Jannin, V., & Bernkop‐Schnürch, A. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.03.027 · Cited by 92
Self-citationAsfour, M. H. (2020) · Drug Delivery and Translational Research · doi:10.1007/s13346-020-00746-z · Cited by 92
Karsdal, M. A., Henriksen, K., Bay‐Jensen, A., Molloy, B., Arnold, M., John, M. R., Byrjalsen, I., Azria, M., Riis, B. J., Qvist, P., et al. (2010) · The Journal of Clinical Pharmacology · doi:10.1177/0091270010372625 · Cited by 91
Self-emulsifying drug delivery systems in oral (poly)peptide drug delivery
Leonavičiǖtė, G., & Bernkop‐Schnürch, A. (2015) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2015.1068287 · Cited by 91
Self-citationInfluence of Emulsifier Structure on Lipid Bioaccessibility in Oil–Water Nanoemulsions
Speranza, A., Corradini, M. G., Hartman, T. G., Ribnicky, D., Oren, A., & Rogers, M. A. (2013) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf401548r · Cited by 90
Exploiting the Vitamin B12 Pathway To Enhance Oral Drug Delivery via Polymeric Micelles
Francis, M. F., Cristea, M., & Winnik, F. M. (2005) · Biomacromolecules · doi:10.1021/bm0503165 · Cited by 86
Development and approval of rybelsus (oral semaglutide): ushering in a new era in peptide delivery
Lewis, A. L., McEntee, N., Holland, J., & Patel, A. (2021) · Drug Delivery and Translational Research · doi:10.1007/s13346-021-01000-w · Cited by 86
The effect of various liposome formulations on insulin penetration across Caco-2 cell monolayer
Değim, Z., Ünal, N., Eşsiz, D., & Abbasoğlu, U. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.05.027 · Cited by 84
Oral Insulin Delivery in a Physiologic Context: Review
Arbit, E., & Kidron, M. (2017) · Journal of Diabetes Science and Technology · doi:10.1177/1932296817691303 · Cited by 83
Xue, H. Y., & Wong, H. L. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2010.12.029 · Cited by 82
Pupo, E., Padrón, A., Santana, E., Sotolongo, J., Quintana, D., Dueñas, S., Duarte, C. A., de la Rosa, M. C., & Hardy, E. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.02.001 · Cited by 82
Shukla, D., Chakraborty, S., Singh, S., & Mishra, B. (2011) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2011.547469 · Cited by 82
Easa, N., Alany, R. G., Carew, M. A., & Vangala, A. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.11.010 · Cited by 82
Development and in vitro characterisation of an oral self-emulsifying delivery system for daptomycin
Zupančič, O., Partenhauser, A., Lam, H. T., Rohrer, J., & Bernkop‐Schnürch, A. (2015) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2015.10.005 · Cited by 81
Self-citationFentahun Darge, H., Yibru Hanurry, E., Simegniew Birhan, Y., Worku Mekonnen, T., Tizazu Andrgie, A., Chou, H.-Y., Lai, J.-Y., & Tsai, H.-C. (2021) · Chemical Engineering Journal · doi:10.1016/j.cej.2020.126879 · Cited by 81
Oral peptide delivery by tetraether lipid liposomes
Parmentier, J., Thewes, B., Gropp, F., & Fricker, G. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.05.066 · Cited by 79
Polymorphism of DNA–anionic liposome complexes reveals hierarchy of ion-mediated interactions
Liang, H., Harries, D., & Wong, G. C. L. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502416102 · Cited by 79
Correlation of Octanol/Water Solubility Ratios and Partition Coefficients
Pinsuwan, S., Li, A., & Yalkowsky, S. H. (1995) · Journal of Chemical & Engineering Data · doi:10.1021/je00019a019 · Cited by 78
Meaney, C., & O’Driscoll, C. M. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00526-3 · Cited by 77
Goblet cell targeting nanoparticle containing drug-loaded micelle cores for oral delivery of insulin
Zhang, P., Xu, Y., Zhu, X. D., et al. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.10.078 · Cited by 76
Lipophilic peptide character – What oral barriers fear the most
Zupančič, O., & Bernkop‐Schnürch, A. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.04.038 · Cited by 76
Self-citationShalaby, T. I. A., & El-Refaie, W. M. (2018) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2018.04.011 · Cited by 76
Leonavičiǖtė, G., Zupančič, O., Prüfert, F., Rohrer, J., & Bernkop‐Schnürch, A. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.04.044 · Cited by 75
Self-citationLong-term oral administration of Exendin-4 to control type 2 diabetes in a rat model
Suzuki, K., Kim, K. S., & Bae, Y. H. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.12.028 · Cited by 75
Yamazoe, E., Fang, J., & Tahara, K. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.120148 · Cited by 74
Nanotechnologies for the delivery of biologicals: Historical perspective and current landscape
Durán‐Lobato, M., López-Estévez, A. M., Cordeiro, A. S., Dacoba, T. G., Crecente‐Campo, J., Torres, D., & Alonso, M. J. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113899 · Cited by 74
Shailubhai, K. (2015) · World Journal of Gastrointestinal Pharmacology and Therapeutics · doi:10.4292/wjgpt.v6.i4.213 · Cited by 73
AboulFotouh, K., Allam, A., El‐Badry, M., & El‐Sayed, A. M. (2018) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2018.03.034 · Cited by 73
El-Laithy, H. M., Basalious, E. B., El-Hoseiny, B. M., & Adel, M. M. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.05.039 · Cited by 72
Chen, C., Fan, T., Jin, Y., Zhou, Z., Yang, Y., Zhu, X. D., Zhang, Z., Zhang, Q., & Huang, Y. (2012) · Nanomedicine · doi:10.2217/nnm.12.141 · Cited by 72
Effects of bile salts on the structural integrity of liposomes
Richards, M. H., & Gardner, C. R. (1978) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(78)90305-7 · Cited by 72
Parmentier, J., Hofhaus, G., Thomas, S., Clusa, L., Gropp, F., Schröder, R. R., Hartmann, K., & Fricker, G. (2014) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24215 · Cited by 71
Strategic approaches for improving entrapment of hydrophilic peptide drugs by lipid nanoparticles
Yuan, H., Jiang, S., Du, Y., Miao, J., Zhang, X., & Hu, F. (2009) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2008.12.031 · Cited by 71
Biomimetic thiamine- and niacin-decorated liposomes for enhanced oral delivery of insulin
He, H., Lü, Y., Qi, J., Zhao, W., Dong, X., & Wu, W. (2017) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2017.11.007 · Cited by 71
Peptide‐Loaded Solid Lipid Nanoparticles Prepared through Coacervation Technique
Gallarate, M., Battaglia, L., Peira, E., & Trotta, M. (2011) · International Journal of Chemical Engineering · doi:10.1155/2011/132435 · Cited by 69
Novel strategy for oral peptide delivery in incretin-based diabetes treatment
Xu, Y., Hul, M. V., Suriano, F., Véronique Préat, A., Cani, P. D., & Beloqui, A. (2019) · Gut · doi:10.1136/gutjnl-2019-319146 · Cited by 69
Lu, H. D., Rummaneethorn, P., Ristroph, K. D., & Prud’homme, R. K. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00824 · Cited by 65
Cell-penetrating self-nanoemulsifying drug delivery systems (SNEDDS) for oral gene delivery
Mahmood, A., Prüfert, F., Efiana, N. A., Ashraf, M., Hermann, M., Hussain, S., & Bernkop‐Schnürch, A. (2016) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2016.1213236 · Cited by 62
Self-citationQuasi-equilibrium analysis of the ion-pair mediated membrane transport of low-permeability drugs
Miller, J. M., Dahan, A., Gupta, D., Varghese, S., & Amidon, G. L. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.02.018 · Cited by 60
Friedl, J. D., Steinbring, C., Zaichik, S., Le, N. N., & Bernkop‐Schnürch, A. (2020) · Nanomedicine · doi:10.2217/nnm-2020-0127 · Cited by 58
Self-citationBile acid transporter-mediated oral absorption of insulin via hydrophobic ion-pairing approach
Bashyal, S., Seo, J., Choi, Y. W., & Lee, S. K. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.08.060 · Cited by 58
Li, N., Li, X., Zhou, Y., Li, W., Zhao, Y. S., Ma, S., Li, J., Gao, Y., Liu, Y., Wang, X., et al. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.08.047 · Cited by 57
Nanotechnology in Insulin Delivery for Management of Diabetes
Bahman, F., Greish, K. F., & Taurin, S. (2019) · Pharmaceutical Nanotechnology · doi:10.2174/2211738507666190321110721 · Cited by 57
Koehl, N. J., Holm, R., Kuentz, M., Jannin, V., & Griffin, B. T. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00305 · Cited by 55
The stimulation of GLP-1 secretion and delivery of GLP-1 agonists via nanostructured lipid carriers
Shrestha, N., Bouttefeux, O., Vanvarenberg, K., Lundquist, P., Cuñarro, J., Tovar, S. A., Khodus, G. R., Andersson, E., Keita, Å. V., Dieguez, C. G., et al. (2017) · Nanoscale · doi:10.1039/c7nr07736j · Cited by 51
Muntoni, E., Marini, E., Ahmadi, N., Milla, P., Ghé, C., Bargoni, A., Capucchio, M. T., Biasibetti, E., & Battaglia, L. (2019) · Acta Diabetologica · doi:10.1007/s00592-019-01403-9 · Cited by 51
Zhang, H., Zhao, L., Chu, L., Han, X., & Zhai, G. (2014) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2014.07.045 · Cited by 50
Chemically modified peptides and proteins - critical considerations for oral delivery
Buckley, S. T., Hubálek, F., & Rahbek, U. L. (2016) · Tissue Barriers · doi:10.1080/21688370.2016.1156805 · Cited by 50
Uptake of Phosphatidylserine Liposomes by Rat Peyer's Patches Following Intraluminal Administration
Tomizawa, H., Aramaki, Y., Fujii, Y., Kara, T., Suzuki, N., Yachi, K., Kikuchi, H., & Tsuchiya, S. (1993) · Pharmaceutical Research · doi:10.1023/a:1018945902276 · Cited by 49
Development and evaluation of insulin-loaded cationic solid lipid nanoparticles for oral delivery
Hecq, J., Amighi, K., & Goole, J. (2016) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2016.10.012 · Cited by 49
Effect of Surface Charges on Oral Absorption of Intact Solid Lipid Nanoparticles
Yu, Z., Fan, W., Wang, L., Qi, J., Lü, Y., & Wu, W. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b00861 · Cited by 49
Multifunctional Delivery Systems for Peptide Nucleic Acids
Volpi, S., Cancelli, U., Neri, M., & Corradini, R. (2020) · Pharmaceuticals · doi:10.3390/ph14010014 · Cited by 48
In vitro and in vivo evaluation of a novel oral insulin formulation
Erli, M., Ma, H., Zheng, L. I. U., Zheng, C., & Duan, M. (2006) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2006.00424.x · Cited by 45
Zhang, Z., Gao, F., Jiang, S., Chen, L., Liu, Z., Yu, H., & Li, Y. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.05.021 · Cited by 44
Christophersen, P. C., Zhang, L., Müllertz, A., Nielsen, H. M., Yang, M., & Mu, H. (2014) · Pharmaceutical Research · doi:10.1007/s11095-014-1337-z · Cited by 44
Michaelsen, M. H., Jorgensen, S., Abdi, I. M., Wasan, K. M., Rades, T., & Müllertz, A. (2019) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2019.07.002 · Cited by 44
Hämmerle, S. P., Mindeholm, L., Launonen, A., Kiese, B., Loeffler, R. L., Harfst, E., Azria, M., Arnold, M., & John, M. R. (2012) · Bone · doi:10.1016/j.bone.2012.01.009 · Cited by 43
Oral delivery of peptide therapeutics in infants: Challenges and opportunities
Gleeson, J. P., Fein, K. C., & Whitehead, K. A. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.03.011 · Cited by 43
Shahzadi, I., Fürst, A., Knoll, P., & Bernkop‐Schnürch, A. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13081312 · Cited by 43
Self-citationVaishya, R. D., Mandal, A., Gokulgandhi, M. R., Patel, S. P., & Mitra, A. K. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.04.075 · Cited by 42
Alqahtani, S., Alayoubi, A. Y., Nazzal, S., Sylvester, P. W., & Kaddoumi, A. (2013) · The AAPS Journal · doi:10.1208/s12248-013-9481-7 · Cited by 42
Chamieh, J., Tarrat, A. D., Doudou, C., Jannin, V., Demarne, F., & Cottet, H. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.01.039 · Cited by 42
Liu, J., Ulrich, W., Funke, M., Besenius, M., Saaby, L., Fanø, M., Mu, H., & Müllertz, A. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.02.014 · Cited by 42
Cytotoxicity and permeability enhancement of Capmul®MCM in nanoemulsion formulation
Bunchongprasert, K., & Shao, J. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.03.010 · Cited by 42
Cited by
Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines
Xiao, W., Jiang, W., Chen, Z., Huang, Y., Mao, J., Zheng, W., Hu, Y., & Shi, J. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02107-5 · Cited by 449
Liposomes as biocompatible and smart delivery systems – the current state
Dymek, M., & Sikora, E. (2022) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2022.102757 · Cited by 392
Nanocarrier system: An emerging strategy for bioactive peptide delivery
Zhang, X., Li, X., Zhao, Y., Zheng, Q., Wu, Q., & Yu, Y. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1050647 · Cited by 63
Local and Systemic Peptide Therapies for Soft Tissue Regeneration: A Narrative Review
Cushman, C. J., Ibrahim, A. F., Smith, A. D., Hernandez, E. J., MacKay, B., & Zumwalt, M. (2024) · The Yale Journal of Biology and Medicine · doi:10.59249/tknm3388 · Cited by 12
“Recently, the number of oral peptide formula - tions in clinical trials has been increasing due to oral drug delivery being a widely preferred method [18].”
Metadata
- Authors
- Haddadzadegan, S., Dorkoosh, F., & Bernkop-Schnürch, A.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2022-03
- Volume
- 182
- Pages
- 114097
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W4206360286
- Cited by
- 424
- References
- 230
- FWCI
- 6.64
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.